Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells

BACKGROUND: The efficacy and safety of multikinase inhibitor anlotinib have been confirmed in the treatment of advanced non-small cell lung cancer (NSCLC). However, the direct functional mechanisms of tumor lethality mediated by anlotinib were not fully elucidated, and the underlying mechanisms rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Lijun, Hui, Kaiyuan, Hu, Chenxi, Wen, Yixuan, Yang, Shikun, Zhu, Panrong, Wang, Lei, Xia, Youyou, Qiao, Yun, Sun, Wen, Fei, Jiayan, Chen, Ting, Zhao, Fenghua, Yang, Baocheng, Jiang, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373028/
https://www.ncbi.nlm.nih.gov/pubmed/30755242
http://dx.doi.org/10.1186/s13046-019-1093-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373028/
https://www.ncbi.nlm.nih.gov/pubmed/30755242
http://dx.doi.org/10.1186/s13046-019-1093-3

Ejemplares similares